These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 26938486)

  • 21. Small molecules targeting HIF-1α pathway for cancer therapy in recent years.
    Tang W; Zhao G
    Bioorg Med Chem; 2020 Jan; 28(2):115235. PubMed ID: 31843464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous injection of siRNA directed against hypoxia-inducible factors prolongs survival in a Lewis lung carcinoma cancer model.
    Kamlah F; Eul BG; Li S; Lang N; Marsh LM; Seeger W; Grimminger F; Rose F; Hänze J
    Cancer Gene Ther; 2009 Mar; 16(3):195-205. PubMed ID: 18818708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced dependency of KRAS-mutant colorectal cancer cells on RAD51-dependent homologous recombination repair identified from genetic interactions in Saccharomyces cerevisiae.
    Kalimutho M; Bain AL; Mukherjee B; Nag P; Nanayakkara DM; Harten SK; Harris JL; Subramanian GN; Sinha D; Shirasawa S; Srihari S; Burma S; Khanna KK
    Mol Oncol; 2017 May; 11(5):470-490. PubMed ID: 28173629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NG25, a novel inhibitor of TAK1, suppresses KRAS-mutant colorectal cancer growth in vitro and in vivo.
    Ma Q; Gu L; Liao S; Zheng Y; Zhang S; Cao Y; Zhang J; Wang Y
    Apoptosis; 2019 Feb; 24(1-2):83-94. PubMed ID: 30515612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of 18F-FDG accumulation in colorectal cancer cells with mutated KRAS.
    Iwamoto M; Kawada K; Nakamoto Y; Itatani Y; Inamoto S; Toda K; Kimura H; Sasazuki T; Shirasawa S; Okuyama H; Inoue M; Hasegawa S; Togashi K; Sakai Y
    J Nucl Med; 2014 Dec; 55(12):2038-44. PubMed ID: 25453050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Digitoxin promotes apoptosis and inhibits proliferation and migration by reducing HIF-1α and STAT3 in KRAS mutant human colon cancer cells.
    Mi C; Cao X; Ma K; Wei M; Xu W; Lin Y; Zhang J; Wang TY
    Chem Biol Interact; 2022 Jan; 351():109729. PubMed ID: 34717917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
    Rohwer N; Cramer T
    Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1alpha and -2alpha.
    Puppo M; Battaglia F; Ottaviano C; Delfino S; Ribatti D; Varesio L; Bosco MC
    Mol Cancer Ther; 2008 Jul; 7(7):1974-84. PubMed ID: 18645007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural products as potent inhibitors of hypoxia-inducible factor-1α in cancer therapy.
    Zhong JC; Li XB; Lyu WY; Ye WC; Zhang DM
    Chin J Nat Med; 2020 Sep; 18(9):696-703. PubMed ID: 32928513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3.
    Nagaraju GP; Park W; Wen J; Mahaseth H; Landry J; Farris AB; Willingham F; Sullivan PS; Proia DA; El-Hariry I; Taliaferro-Smith L; Diaz R; El-Rayes BF
    Angiogenesis; 2013 Oct; 16(4):903-17. PubMed ID: 23838996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting both HIF-1 and HIF-2 in human colon cancer cells improves tumor response to sunitinib treatment.
    Burkitt K; Chun SY; Dang DT; Dang LH
    Mol Cancer Ther; 2009 May; 8(5):1148-56. PubMed ID: 19435875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific inhibition of p110α subunit of PI3K: putative therapeutic strategy for KRAS mutant colorectal cancers.
    Fernandes MS; Melo S; Velho S; Carneiro P; Carneiro F; Seruca R
    Oncotarget; 2016 Oct; 7(42):68546-68558. PubMed ID: 27602501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer.
    Jarman EJ; Ward C; Turnbull AK; Martinez-Perez C; Meehan J; Xintaropoulou C; Sims AH; Langdon SP
    Breast Cancer Res; 2019 Jan; 21(1):10. PubMed ID: 30670058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diacetoxyscirpenol as a new anticancer agent to target hypoxia-inducible factor 1.
    Choi YJ; Shin HW; Chun YS; Leutou AS; Son BW; Park JW
    Oncotarget; 2016 Sep; 7(38):62107-62122. PubMed ID: 27613833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dolastatin 15 from a Marine Cyanobacterium Suppresses HIF-1α Mediated Cancer Cell Viability and Vascularization.
    Ratnayake R; Gunasekera SP; Ma JJ; Dang LH; Carney TJ; Paul VJ; Luesch H
    Chembiochem; 2020 Aug; 21(16):2356-2366. PubMed ID: 32237262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type Colorectal Cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis.
    Chu YC; Tsai TY; Yadav VK; Deng L; Huang CC; Tzeng YM; Yeh CT; Chen MY
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the Therapeutic Potential of Fe
    Mahdavi Niyaki Z; Salehzadeh A; Peymani M; Zaefizadeh M
    Biol Trace Elem Res; 2024 Jul; 202(7):3073-3085. PubMed ID: 37792268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PDEδ inhibition impedes the proliferation and survival of human colorectal cancer cell lines harboring oncogenic KRas.
    Klein CH; Truxius DC; Vogel HA; Harizanova J; Murarka S; Martín-Gago P; Bastiaens PIH
    Int J Cancer; 2019 Feb; 144(4):767-776. PubMed ID: 30194764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
    Costa-Cabral S; Brough R; Konde A; Aarts M; Campbell J; Marinari E; Riffell J; Bardelli A; Torrance C; Lord CJ; Ashworth A
    PLoS One; 2016; 11(2):e0149099. PubMed ID: 26881434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential roles of Sirt1 in HIF-1α and HIF-2α mediated hypoxic responses.
    Yoon H; Shin SH; Shin DH; Chun YS; Park JW
    Biochem Biophys Res Commun; 2014 Jan; 444(1):36-43. PubMed ID: 24423936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.